Results 211 to 220 of about 164,168 (220)
Some of the next articles are maybe not open access.
Inhibition of angiopoietin-like protein 3 as a target for managing hypertriglyceridemia
Current Opinion in Endocrinology, Diabetes & ObesityPurpose of review To summarize recent advances in therapeutic strategies targeting angiopoietin-like protein 3 (ANGPTL3), a central regulator of triglyceride and remnant lipoprotein metabolism, and to discuss the potential of emerging pharmacologic approaches
Pablo, Corral +2 more
openaire +2 more sources
A tale of two angiopoietin-like proteins
Current Opinion in Lipidology, 2007openaire +2 more sources
Angiopoietin-Like Protein 3 Inhibition
Journal of the American College of CardiologyErik S.G. Stroes +2 more
openaire +1 more source
Angiopoietin-like 4 Interacts with Matrix Proteins to Modulate Wound Healing*
Journal of Biological Chemistry, 2010Yan Yih Goh, Mintu Pal, Han Chung Chong
exaly
Angiopoietin-like protein 4: A therapeutic target for triglycerides and coronary disease?
Journal of Clinical Lipidology, 2018David S Olshan, Daniel J Rader
exaly
[Role of angiopoietin-like protein (Angptl)].
Seikagaku. The Journal of Japanese Biochemical Society, 2006openaire +1 more source
[Progress in the study of angiopoietin-like protein 3].
Sheng li ke xue jin zhan [Progress in physiology], 2010Xiao-Yan, Zhang, You-Fei, Guan
openaire +1 more source

